Akebia Therapeutics (AKBA) EBIT (2013 - 2026)
Akebia Therapeutics (AKBA) reported EBIT of -$6.33 million for Q2 2026, compared with $14.09 million a year earlier.
Powered by 
Analysis
Akebia Therapeutics (AKBA) EBIT (2013 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Akebia Therapeutics' EBIT came in at -$15.13 million; for FY2025, it was $23.5 million.
- By year, EBIT came in at -$50.47 million in FY2024, -$46.26 million in FY2023, -$80.78 million in FY2022 and -$264.5 million in FY2021.
- Five-year quarterly EBIT spans a low of -$65.34 million in Q4 2021 and a high of $34.08 million in Q2 2022.
- Per Business Quant data, the three quarters before Q2 2026 came in at -$4.7 million (Q1 2026), -$8.55 million (Q4 2025) and $4.45 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.22 Bn | 1,098.80 Bn | 19.71 Bn | 11.75 Bn |
| 2 | Johnson & Johnson | 614.95 Bn | 533.47 Bn | 17.26 Bn | 7.14 Bn |
| 3 | AbbVie | 505.05 Bn | 478.16 Bn | 12.70 Bn | 6.43 Bn |
| 4 | Merck | 368.08 Bn | 322.46 Bn | 12.21 Bn | -584.00 Mn |
| 5 | Novartis Ag | 298.32 Bn | 262.31 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 261.58 Bn | 235.26 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 236.05 Bn | 191.45 Bn | 7.24 Bn | 3.51 Bn |
| 8 | Gilead Sciences | 190.61 Bn | 164.80 Bn | 6.22 Bn | -10.39 Bn |
| 9 | Pfizer | 169.86 Bn | 116.50 Bn | 10.94 Bn | 4.27 Bn |
| 10 | Akebia Therapeutics | 163.03 Mn | -506.45 Mn | 38.70 Mn | -6.33 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -6.33 Mn |
| Mar 31, 2026 | -4.70 Mn |
| Dec 31, 2025 | -8.55 Mn |
| Sep 30, 2025 | 4.45 Mn |
| Jun 30, 2025 | 14.09 Mn |
| Mar 31, 2025 | 13.51 Mn |
| Dec 31, 2024 | -14.31 Mn |
| Sep 30, 2024 | -12.51 Mn |
| Jun 30, 2024 | -8.73 Mn |
| Mar 31, 2024 | -14.94 Mn |
| Dec 31, 2023 | 1.37 Mn |
| Sep 30, 2023 | -13.04 Mn |
| Jun 30, 2023 | -9.00 Mn |
| Mar 31, 2023 | -25.60 Mn |
| Dec 31, 2022 | -4.87 Mn |
| Sep 30, 2022 | -50.41 Mn |
| Jun 30, 2022 | 34.08 Mn |
| Mar 31, 2022 | -59.58 Mn |
| Dec 31, 2021 | -65.34 Mn |
| Sep 30, 2021 | -54.89 Mn |
API Access
Akebia Therapeutics EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=AKBA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "AKBA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=AKBA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();